During the past decade, Joint Clinical Research Centre conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 11 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Joint Clinical Research Centre" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "AIDS Clinical Trials Group" with 5 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored, "University of Minnesota" with 4 trials sponsored and "Drugs for Neglected Diseases" with 4 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Joint Clinical Research Centre" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "Joint Clinical Research Centre- Kampala" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "Joint Clinical Research Centre" are "HIV Infections" (8 trials), "HIV" (6 trials), "HIV Infection" (5 trials), "HIV-1 Infection" (3 trials) and "Tuberculosis" (3 trials). Many other conditions were trialed in "Joint Clinical Research Centre" in a lesser frequency.

Most popular intervention types in "Joint Clinical Research Centre" are "Drug" (26 trials), "Biological" (4 trials), "Other" (4 trials), "Dietary Supplement" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "E/C/F/TAF" (3 trials), "ATV" (2 trials), "Efavirenz" (2 trials) and "Isoniazid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Joint Clinical Research Centre" are 31 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Joint Clinical Research Centre". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Joint Clinical Research Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Joint Clinical Research Centre, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".